MEI Pharma Announces Material Agreement Termination & Officer Changes
Ticker: LITS · Form: 8-K · Filed: Jul 22, 2025 · CIK: 1262104
| Field | Detail |
|---|---|
| Company | Mei Pharma, INC. (LITS) |
| Form Type | 8-K |
| Filed Date | Jul 22, 2025 |
| Risk Level | medium |
| Sentiment | mixed |
Sentiment: mixed
Topics: agreement-termination, officer-changes, equity-sale
TL;DR
MEI Pharma terminated a big deal, changed some execs, and sold more stock.
AI Summary
MEI Pharma, Inc. announced on July 17, 2025, the termination of a material definitive agreement. The company also reported on unregistered sales of equity securities and changes in its board and officer composition, including the departure of directors and the election of new officers. Additionally, MEI Pharma entered into a material definitive agreement and reported other events.
Why It Matters
This filing indicates significant corporate actions, including the end of a key agreement and changes in leadership, which could impact the company's strategic direction and operational stability.
Risk Assessment
Risk Level: medium — The termination of a material definitive agreement and unregistered sales of equity securities can signal financial distress or strategic shifts, warranting closer scrutiny.
Key Players & Entities
- MEI Pharma, Inc. (company) — Registrant
- July 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Diego (location) — Business address city
FAQ
What was the material definitive agreement that was terminated?
The filing does not specify the details of the terminated material definitive agreement.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 17, 2025.
What are the main items reported in this 8-K filing?
The filing reports on the entry into and termination of material definitive agreements, unregistered sales of equity securities, departure/election of directors and officers, and other events.
Where is MEI Pharma, Inc. headquartered?
MEI Pharma, Inc.'s business address is in San Diego, California.
What is the SEC file number for MEI Pharma, Inc.?
The SEC file number for MEI Pharma, Inc. is 001-41827.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 22, 2025 regarding MEI Pharma, Inc. (LITS).